In 1992, Romach and colleagues described that dose escalation is not a characteristic of prolonged-expression alprazolam users and that the majority of long-expression alprazolam people transform their Preliminary pattern of standard use to at least one of symptom Command only when expected.[74]No single formulation meets the necessities of all suf